 |
|
|
| |
Treatment of HCV-induced cryoglobulinemic vasculitis with new direct acting antiviral (DAA) regimens
|
| |
| |
Reported by Jules Levin
AASLD Annual Meeting 2017, Washington, DC, USA, October 20-24
Cristin D 1; Wieland A 1; Langness J 1; Kuo A 2; Darling J 3; Morelli G 4; Lim JK 5; Feld J 6; Nelson DR 4; Fried MW 3; Vainorius M 3; Everson G 1
1 University of Colorado, Aurora, CO; 2University of San Diego, San Diego, CA; 3University of North Carolina, Chapel Hill, NC; 4University of Florida, Gainesville, FL; 5Yale University SOM, New Haven, CT; 6Toronto Western Hospital Liver Center, Toronto, Canada
|
| |
|
|
|
|
|
